AVAI BIO, INC. financial data

Symbol
AVAI on OTC
Location
Las Vegas, NV
Fiscal year end
31 March
Latest financial report
10-Q - Q4 2025 - 12 Feb 2026

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 3% % 19%
Debt-to-equity -109% % 3%
Return On Equity -1510% % -961%
Return On Assets -532% % 36%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 138,252,252 shares 0.82%
Common Stock, Shares, Outstanding 138,031,533 shares 0.66%
Entity Public Float $65,934,486 USD -43%
Common Stock, Value, Issued $138,032 USD 0.66%
Weighted Average Number of Shares Outstanding, Basic 138,029,337 shares 0.75%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense $23,804 USD
General and Administrative Expense $494,021 USD -23%
Operating Income (Loss) $3,182,948 USD 6.6%
Nonoperating Income (Expense) $23,400 USD
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $452,298 USD 55%
Net Income (Loss) Attributable to Parent $1,030,260 USD 46%
Earnings Per Share, Basic 0 USD/shares

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $50,402 USD 1542%
Assets, Current $60,852 USD 121%
Property, Plant and Equipment, Net $1,500 USD 0%
Intangible Assets, Net (Excluding Goodwill) $118,577 USD -29%
Assets $172,912 USD -1.1%
Accounts Payable, Current $1,399,400 USD -11%
Liabilities, Current $2,967,398 USD 28%
Liabilities $2,967,398 USD 28%
Retained Earnings (Accumulated Deficit) $5,612,842 USD -22%
Stockholders' Equity Attributable to Parent $2,794,486 USD -31%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $1,563,872 USD -6.6%
Liabilities and Equity $172,912 USD -1.1%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $240,343 USD -1792%
Net Cash Provided by (Used in) Financing Activities $169,352 USD 1216%
Common Stock, Shares Authorized 500,000,000 shares 0%
Common Stock, Shares, Issued 138,031,533 shares 0.66%
Common Stock, Par or Stated Value Per Share 0.001 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $50,402 USD 1542%
Deferred Tax Assets, Valuation Allowance $864,887 USD 38%
Deferred Tax Assets, Gross $864,887 USD 38%
Depreciation $1,500 USD
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $1,100,861 USD 51%
Property, Plant and Equipment, Gross $1,500 USD
Deferred Tax Assets, Operating Loss Carryforwards $4,118,510 USD 38%
Preferred Stock, Shares Issued 11,300,000 shares 0%
Preferred Stock, Shares Authorized 20,000,000 shares 0%
Additional Paid in Capital $2,653,774 USD 16%
Preferred Stock, Shares Outstanding 11,300,000 shares 0%
Depreciation, Depletion and Amortization $6,518 USD -67%
Preferred Stock, Par or Stated Value Per Share 0.001 USD/shares 0%